Meeting Details

  • Date: Tuesday, September 29, 2026
  • Time: Commenced at 11:30 A.M.
  • Location: Conducted through Video Conferencing (VC)
  • Deemed Venue: Registered Office at Ambala-Chandigarh Highway, Lalru - 140501, Punjab, India
  • Type: 42nd Annual General Meeting

Attendees

Directors Present:

  • Mr. Sandeep Jain, Joint Managing Director and Promoter Shareholder
  • Dr. Sanjay Trehan, Director Technical & Compliances
  • Mrs. Ambika Sharma, Independent Director
  • Mr. Krishan Kumar Jalan, Independent Director (Elected Chairman)
  • Dr. Rajender Pal Singh, Independent Director
  • Mr. Rajinder Singh Manku, Independent Director
  • Dr. Venkatesh Savasiddhi, Independent Director

Officials Present:

  • Mr. Vinod Goel, Group CFO and Head Legal & Corporate Governance
  • Dr. Khalid Ali Syed, Chief Scientific Officer
  • Mr. Ankit Jain, General Manager Legal & Company Secretary and Compliance Officer
  • Mr. Amit Saraswat, General Manager Business & Operating Finance
  • Mr. Amit Gupta, General Manager Accounts & Taxation
  • Ms. Ritu Dhyani, Manager Secretarial & Compliance

External Attendees:

  • Mr. Kapil Kedar, Partner and Mr. Raman Goyal, Assistant General Manager of M/s Suresh Surana & Associates LLP (Statutory Auditors)
  • Mr. Debabrata Deb Nath, Partner of M/s R&D Company Secretaries (Secretarial Auditors and Scrutinizer)

Absent Directors:

  • Dr. Rajesh Jain, Chairman and Managing Director (due to other pre-occupation)
  • Mr. Ankesh Jain, Whole-time Director (due to prior commitments)
  • Mr. Harshet Jain, Whole-time Director (due to prior engagements)

Resolutions Proposed

Ordinary Business:

1. Adoption of Audited Standalone Financial Statements for FY ended March 31, 2026 with reports of Board of Directors and Auditors (Ordinary Resolution)

2. Adoption of Audited Consolidated Financial Statements for FY ended March 31, 2026 with Auditors' Report (Ordinary Resolution)

3. Re-appointment of Mr. Ankesh Jain as retiring director (Ordinary Resolution)

4. Re-appointment of Mr. Harshet Jain as retiring director (Ordinary Resolution)

Special Business:

5. Appointment of Mr. Rajinder Singh Manku as an independent director (Special Resolution)

6. Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for FY 2026-27 (Ordinary Resolution)

Voting Process

  • Remote e-voting period: September 26, 2026 (9:00 AM IST) to September 28, 2026 (5:00 PM IST)
  • Cut-off date for membership: Tuesday, September 22, 2026
  • E-voting at AGM: Available for members who did not use remote e-voting, open for 30 minutes after conclusion of AGM
  • Scrutinizer: Mr. Debabrata Deb Nath, Partner of M/s R&D Company Secretaries appointed to scrutinize remote e-voting and e-voting at AGM

Document Availability

  • Statutory Registers under Companies Act, Auditors' Report, Secretarial Audit Report and other documents were available for electronic inspection during meeting
  • Notice of AGM and Annual Report for FY ended March 31, 2026 were taken as read as already circulated

Auditor Reports

  • Statutory Auditors' Report: No qualifications/reservations/adverse remarks on Financial Statements. Management's response provided in Notes to Financial Statements and Directors' Report
  • Secretarial Audit Report: No qualifications/reservations/adverse remarks. Contains two observations with responses provided in Directors' Report

Shareholder Engagement

  • Company received advance queries from shareholders which were replied to
  • Registered speakers raised queries regarding financial performance, status of vaccines under development, regulatory approval processes for vaccines, progress on USFDA and EU GMP approvals for pharmaceuticals formulation facility, regulatory approvals for new hexavalent vaccine capacity enhancement facilities, and future plans of the Company
  • Management noted queries and will provide replies in due course

Voting Results and Compliance

  • Voting results along with consolidated Scrutinizer's Report will be declared within prescribed timelines latest by October 1, 2026
  • Results will be placed on Company's website and website of National Securities Depository Limited
  • Results will be communicated to BSE Limited (Scrip Code: 531349) and National Stock Exchange of India Limited (NSE Symbol: PANACEABIO)
  • Results will be displayed on notice board at Registered Office and Corporate Office
  • Meeting concluded at 12:12 P.M.

Compliance References

  • Conducted in accordance with Companies Act, 2013 and rules thereunder
  • SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • General Circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India
  • Secretarial Standards on General Meeting (SS-2) issued by Institute of Company Secretaries of India
  • Regulation 44 of SEBI LODR Regulations for voting results disclosure